Skip to main content
Caplight Logo









SynBioLab

SynBioLab

Private
JiaxingHealthcare & Life Scienceshttps://synbiolab.cn

Last Round

Series A

Feb 13, 2023

Total Funding Raised

$1.55M

Company Overview

SynBioLab is a biotechnology company that develops microbial cell factories to produce high-value-added plant-derived medicinal compounds and chemical raw materials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologymicrobial cell factoriesstrain engineeringbiomanufacturingcontract research organizationCROmetabolic engineeringbio-based manufacturingsynbiobioprocess developmentenzyme optimizationindustrial biotechnologyprecision fermentationpharmaceutical intermediatesnatural compounds

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SynBioLab Comparables

Compare SynBioLab with similar companies based on industry and business-model similarity.

SynBioLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cataya Bio
87%
Bota Biosciences
83%
Hangzhou Viablife Biotech Co., Ltd.
81%

SynBioLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 13, 2023
Early FundingSep 30, 2021

SynBioLab Investors

Notable investors and investment history

SynBioLab investors
InvestorRounds
Green Leaf VenturesSeries A
Bangming CapitalSeries A
Kaitai CapitalEarly Funding
松禾资本 (Green Pine Capital Partners)Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2023

    Raised Series A with Green Leaf Ventures and Bangming Capital.

  • Sep 30, 2021

    $1.55M raised, led by Kaitai Capital.

SynBioLab Filings

Explore SEC and related filing metadata, where available.

SynBioLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SynBioLab's valuation, stock price, and market status.

Is SynBioLab a public or private company?

SynBioLab is a private company.

What is the current stock price of SynBioLab?

SynBioLab is a private company with no public stock price. Caplight tracks SynBioLab's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is SynBioLab worth (valuation)?

Valuation information for SynBioLab is not publicly available.

Can I buy SynBioLab stock?

SynBioLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SynBioLab's last funding round?

Funding round information for SynBioLab is not publicly available.

Who are the main investors in SynBioLab?

Investor information for SynBioLab is not publicly disclosed.

Will SynBioLab IPO soon?

No public IPO plans have been announced for SynBioLab.

How can I track SynBioLab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynBioLab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJiaxing
Year Founded2017
Last FundingFeb 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?